Nexalin Technology (NXL) News Today $1.19 -0.02 (-1.65%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$1.20 +0.01 (+0.42%) As of 05/28/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3May 28 at 12:40 PM | finance.yahoo.comJoin Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on June 3May 28 at 10:00 AM | globenewswire.comNexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging DataMay 13, 2025 | finance.yahoo.comNexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer's Program Amid Encouraging DataMay 13, 2025 | globenewswire.comNexalin Technology, Inc. Closes Public Offering of 3,850,000 Shares at $1.30 Per Share, Raising $5.0 MillionMay 6, 2025 | quiverquant.comNexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public OfferingMay 6, 2025 | globenewswire.comNexalin Technology Announces Pricing of $5.0 Million Public Offering of Common StockMay 5, 2025 | globenewswire.comNexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA FeedbackMay 1, 2025 | globenewswire.comNexalin Technology receives IRB approval in Brazil, begins trialApril 24, 2025 | markets.businessinsider.comNexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and InsomniaApril 24, 2025 | globenewswire.comNexalin completes five phases of virtual clinic, digital research systemApril 24, 2025 | markets.businessinsider.comNexalin Technology files $50M common stock offeringApril 23, 2025 | msn.comNexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient ManagementApril 23, 2025 | globenewswire.comNexalin Technology expresses ‘strong support’ for Health Tech Investment ActApril 22, 2025 | markets.businessinsider.comNexalin Technology, Inc. Supports Health Tech Investment Act to Enhance Medicare Reimbursement for AI-Enabled Medical DevicesApril 21, 2025 | quiverquant.comNexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled DevicesApril 21, 2025 | globenewswire.comNexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use DisordersApril 14, 2025 | globenewswire.comNexalin enrolls first patients, advances toward treatment in UCSD trialApril 4, 2025 | markets.businessinsider.comNexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical TrialApril 2, 2025 | globenewswire.comJoin Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3March 26, 2025 | markets.businessinsider.comJoin Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3March 26, 2025 | globenewswire.comNexalin Technology upgraded to Buy from Hold at MaximMarch 25, 2025 | markets.businessinsider.comMaxim Group Upgrades Nexalin Technology (NXL)March 24, 2025 | msn.comNexalin Technology, Inc. (NASDAQ:NXL) VP Carolyn Hamby Shelton Buys 6,000 SharesMarch 14, 2025 | insidertrades.comNexalin receives a Notice of Allowance from USPTO for patent on DIFSMarch 4, 2025 | markets.businessinsider.comNexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use DisordersMarch 3, 2025 | globenewswire.comNexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB ApprovalMarch 1, 2025 | markets.businessinsider.comNexalin Technology announces initiation of patient recruitment in UCSD studyMarch 1, 2025 | markets.businessinsider.comNexalin Technology Announces Initiation of Patient Recruitment for UCSD's TBI & PTSD Clinical Study Following IRB ApprovalFebruary 28, 2025 | globenewswire.comNexalin Technology appoints Wesley Clark to Military, Government Advisory BoardFebruary 26, 2025 | markets.businessinsider.comNexalin Technology Welcomes General Wesley Clark to Military & Government Advisory BoardFebruary 26, 2025 | globenewswire.comNexalin Technology’s HALO Clarity headset approved for use in trials by UCSDFebruary 18, 2025 | markets.businessinsider.comNexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD TreatmentFebruary 18, 2025 | globenewswire.comNexalin appointed industry co-chair of National TBI Registry CoalitionFebruary 10, 2025 | markets.businessinsider.comNexalin Appointed as Industry Co-Chair of National TBI Registry CoalitionFebruary 10, 2025 | globenewswire.comNexalin Technology announces effective registration statementFebruary 6, 2025 | msn.comNexalin technology's chief medical officer buys $3,100 in sharesFebruary 5, 2025 | msn.comNexalin technology's chief medical officer buys $2,980 in common stockFebruary 5, 2025 | msn.comNexalin Technology announces publication of study of DIFS technologyFebruary 3, 2025 | markets.businessinsider.comNexalin Technology, Inc. Reports Landmark Study Highlights Efficacy of DIFS™ Technology in Reducing Blood Pressure in Patients with Major Depressive DisorderFebruary 3, 2025 | quiverquant.comNexalin's Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark StudyFebruary 3, 2025 | globenewswire.comNexalin technology's chief medical officer buys $4,050 in stockJanuary 30, 2025 | msn.comNexalin technology's chief medical officer buys $7,700 in stockJanuary 24, 2025 | msn.comJoin Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23January 23, 2025 | finance.yahoo.comJoin Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session, Today, January 23January 23, 2025 | globenewswire.comNexalin Technology, Inc.: Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025January 14, 2025 | finanznachrichten.deNexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025January 14, 2025 | markets.businessinsider.comNexalin Technology Completes Phase 1of its Innovative Virtual ClinicDecember 23, 2024 | globenewswire.comMaxim Group Downgrades Nexalin Technology (NXL)December 6, 2024 | msn.comShort Interest in Nexalin Technology, Inc. (NASDAQ:NXL) Drops By 51.7%Nexalin Technology, Inc. (NASDAQ:NXL - Get Free Report) was the target of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 622,600 shares, a decrease of 51.7% from the October 31st total of 1,290,000 shares. Approximately 6.3% of the company's shares are sold short. Based on an average daily volume of 1,580,000 shares, the short-interest ratio is currently 0.4 days.November 28, 2024 | marketbeat.com Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address NXL Media Mentions By Week NXL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NXL News Sentiment▼1.020.85▲Average Business Services News Sentiment NXL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NXL Articles This Week▼41▲NXL Articles Average Week Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Vivani Medical News Carmell News Nutriband News SurgePays News IceCure Medical News Apyx Medical News Cytosorbents News Hyperfine News Alpha Pro Tech News TELA Bio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NXL) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NXL Stock Free NXL Stock Alerts